Morgan Stanley 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-06 4:28 pm Sale | 2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 1,012,337 1.600% | -3,530,655 (-77.72%) | Filing |
| 2025-02-05 10:41 am Purchase | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 4,542,992 7.400% | 4,542,992 (New Position) | Filing |